Clovis Oncology, Inc.
USD0.08
+0.00 (+0.00%)
CEO
Patrick Mahaffy
IPO Date
2011-11-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.08
Prev. Close
$0.08
Day Low
$0.08
Day High
$0.10
52W Low
$0.04
52W High
$3.25
Volume
24.21M
| -1.1 |
| 31 Dec 2019 | FY | 75.7% | -280.0% | 229.8% | -59.8% | -3.93 | 2.75 | -1.4 |
| 31 Dec 2018 | FY | 76.9% | -385.8% | -251.3% | -42.6% | 3.94 | 4.55 | -2.5 |
| 31 Dec 2017 | FY | 78.9% | -624.0% | -94.2% | -47.1% | 1.04 | 7.69 | -9.2 |
| 31 Dec 2016 | FY | 10.3% | -447611.5% | 9607.5% | -95.8% | -91.12 | 4.26 | -4.9 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -117.4% | -49.5% | 1.76 | 7.14 | -3.6 |
| 31 Dec 2014 | FY | -1063.0% | -1174.5% | -48.3% | -20.4% | 0.87 | 10.28 | -11.9 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -17.0% | -13.0% | 0.00 | 15.68 | -20.4 |
| 31 Dec 2012 | FY | 0.0% | 0.0% | -55.4% | -50.7% | 0.00 | 11.91 | -5.4 |
| -0.9 |
| 31 Mar 2022 | Q1 | 72.5% | -175.7% | 19.8% | -13.3% | -2.15 | 1.52 | -1.2 |
| 31 Dec 2021 | Q4 | 72.9% | -179.0% | 23.1% | -13.6% | -2.29 | 1.58 | -1.3 |
| 30 Sept 2021 | Q3 | 74.0% | -177.8% | 29.9% | -13.3% | -2.77 | 2.05 | -2.0 |
| 30 Jun 2021 | Q2 | 73.8% | -180.5% | 32.1% | -11.6% | -3.25 | 1.70 | -2.4 |
| 31 Mar 2021 | Q1 | 74.7% | -174.2% | 30.0% | -12.1% | -3.01 | 1.46 | -2.8 |
| 31 Dec 2020 | Q4 | 75.0% | -228.5% | 62.3% | -16.3% | -4.08 | 1.68 | -1.1 |
| 30 Sept 2020 | Q3 | 74.8% | -202.9% | 48.2% | -13.3% | -3.89 | 2.33 | -1.6 |
| 30 Jun 2020 | Q2 | 73.9% | -231.3% | 94.7% | -14.7% | -6.33 | 2.87 | -1.5 |